ARAV - Aravive Inc
IEX Last Trade
0.228
-0.020 -8.947%
Share volume: 6,895,081
Last Updated: Tue 08 Aug 2023 09:59:54 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.25
-0.02
-8.21%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
Report Date | 2022-05-12 | 2022-08-11 | 2022-11-10 | 2023-03-15 | 2023-05-10 | 2023-08-21 | 2023-11-09 | |
Assets | ||||||||
Total Assets | 73.871 M | 55.891 M | 42.222 M | 62.153 M | 43.044 M | 25.737 M | 13.049 M | |
Current Assets | 69.052 M | 51.291 M | 37.839 M | 57.970 M | 39.063 M | 22.045 M | 9.562 M | |
Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Other Current Assets | 3.227 M | 4.458 M | 3.943 M | 4.281 M | 3.139 M | 3.686 M | 1.027 M | |
Short Term Investments | 3.227 M | 4.458 M | 3.943 M | 4.281 M | 3.139 M | 3.686 M | 1.027 M | |
Total Receivables | 0.000 | 0.000 | 6.000 M | 0.000 | 0.000 | 0.000 | 0.000 | |
Current Cash | 65.825 M | 46.833 M | 27.896 M | 53.689 M | 35.924 M | 18.359 M | 8.535 M | |
Total Non-current Assets | 4.819 M | 4.600 M | 4.383 M | 4.183 M | 3.981 M | 3.692 M | 3.487 M | |
Property Plant Equipment | 365.000 K | 330.000 K | 295.000 K | 270.000 K | 240.000 K | 204.000 K | 167.000 K | |
Other Assets | 2.023 M | 1.839 M | 1.652 M | 1.468 M | 1.283 M | 1.096 M | 912.000 K | |
Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Liabilities and shareholders’ equity | ||||||||
Total Liabilities and shareholders’ equity | 73.871 M | 55.891 M | 42.222 M | 62.153 M | 43.044 M | 25.737 M | 13.049 M | |
Total liabilities | 34.672 M | 25.825 M | 27.180 M | 51.496 M | 81.655 M | 45.554 M | 11.348 M | |
Total current liabilities | 19.780 M | 21.470 M | 23.730 M | 22.112 M | 20.192 M | 14.221 M | 9.777 M | |
Accounts Payable | 4.246 M | 4.700 M | 8.821 M | 8.765 M | 9.794 M | 3.893 M | 5.423 M | |
Other liabilities | 11.376 M | 1.389 M | 1.024 M | 27.502 M | 60.116 M | 30.512 M | 1.265 M | |
Current long term debt | 2.271 M | 2.245 M | 2.220 M | 2.195 M | 2.170 M | 2.145 M | 2.121 M | |
Long term debt | 3.516 M | 2.966 M | 2.426 M | 1.882 M | 1.347 M | 821.000 K | 306.000 K | |
Other liabilities | 11.376 M | 1.389 M | 1.024 M | 27.502 M | 60.116 M | 30.512 M | 1.265 M | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | 39.199 M | 30.066 M | 15.042 M | 10.657 M | -38.611 M | -19.817 M | 1.701 M | |
Common stock | 21.130 M | 30.505 M | 30.518 M | 63.335 M | 75.715 M | 75.727 M | 75.739 M | |
Retained earnings | -552.862 M | -571.339 M | -587.002 M | -616.127 M | -666.083 M | -648.075 M | -626.849 M |